HIV/AIDS Treatment in India

See also: India & HIV/AIDS

India: Free-Trade Proposal May Affect Supply of AIDS Drugs (February 13, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Proposed Intellectual Property Agreement Between E.U., India Could Affect Generic Drug Exports, Advocacy Groups Say (February 10, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
23 Indian Children Get HIV From Blood Transfusions (September 12, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
India Will Continue to Produce Generic HIV Drugs, Commerce and Industry Minister Says (July 7, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Protesters Call on Indian Government to Reject Free Trade Agreement With EU (March 3, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Conference for HIV/AIDS Clinicians Opens in Mumbai (February 8, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Financial Times Examines Pharma's Growing Interest in India (January 27, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Health Groups Hail India's AIDS Drug Patent Move (January 13, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Indian Government Rejects Abbott's Patent Application for Second-Line ARV (January 4, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
EU, India Leaders Meet to Discuss Trade Deal, Some Concerned Deal Will Jeopardize Drug Access in Developing Countries (December 10, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
India, EU Trade Agreement Will Not Restrict Ability for India Pharmaceutical Firms to Export Generic Drugs, Official Says (December 8, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
PHARMABIZ.com Examines India's Push for Clearer Definition of Counterfeit, Substandard Medicines (October 28, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
India's Trade Minister Says EU Will Take Steps to Prevent Seizure of Generic Medicines (October 22, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Most HIV-Positive Indians Not Receiving Treatment on Time, Global Fund Says (September 9, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
India's AIDS Activists Unsure of Epidemic's Future (July 15, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
India, Brazil Launch Trade Dispute Against EU, Netherlands Over Seizures of Generic Drugs (May 13, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Trade Negotiations Between EU, India Could Affect Access to Low-Cost Generics (April 27, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
EU-India Free-Trade Negotiations Could Limit Access to Affordable, Generic Drugs, Advocacy Group Says (March 16, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Indian AIDS Drug Receives WHO Approval (November 12, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Indian Health Officials Welcome Patent Rejections of HIV/AIDS Drugs (September 9, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Access to Second-Line Antiretrovirals In India (June 9, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
India's Cipla Gets Tentative U.S. Nod for AIDS Drug (May 5, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HIV-Positive People in Indian State Experience Limited Access to Second-Line Antiretrovirals (February 2, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Indian Railways Considers Offering Fare Concessions to HIV-Positive People to Facilitate Travel to NACO Treatment Centers (January 3, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
GlaxoSmithKline Withdraws Patent Applications for Antiretrovirals Abacavir, Trizivir in India (December 10, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
India Nearly Doubles Treatment Centers Offering HIV/AIDS Drugs at No Cost, Official Says (October 2, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
AIDS Treatment Costs Less Than a Coffee a Day, Yet Many Indians Die Early (July 25, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
India Changes Patent Law to Meet WTO Treaty, Making New Medicines Less Available to Most Citizens, Other Countries (December 31, 2004)
In AIDS Treatment News, from AIDS Treatment News
Government of India and Clinton Foundation Sign Agreement to Scale Up HIV Care and Treatment (September 30, 2004)
To read PDF, click here.
From UNAIDS
Progress on Antiretroviral Access in India: Interview With Khousalya Periaswamy (May/June 2004)
Ms. Periaswamy is the president of the Positive Women's Network, an AIDS advocacy/service organization in India.
In GMHC Treatment Issues, from Gay Men's Health Crisis
AstraZeneca to Invest in Indian TB Facility (June 2, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Burkina Faso to Purchase Generic AIDS Drugs From Indian Company (April 23, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Treatment Models From India (March 17, 2000)
Interview with Shashank Joshi, M.D.
In AIDS Treatment News, from AIDS Treatment News